Literature DB >> 11724830

Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR.

F Damond1, D Descamps, I Farfara, J N Telles, S Puyeo, P Campa, A Leprêtre, S Matheron, F Brun-Vezinet, F Simon.   

Abstract

We have developed and evaluated a new method to quantify human immunodeficiency virus type 2 (HIV-2) proviral DNA based on LightCycler real-time PCR. The assay has a detection limit of 5 copies/10(5) peripheral blood mononuclear cells (PBMC) and is insensitive to HIV-2 strain variability: HIV-2 subtypes A and B are both recognized and quantified. The intra- and interassay coefficients of variation range from 16 to 40% for high provirus concentrations (5 x 10(5) copies) and from 41 to 39% for low concentrations (5 copies). We used this method to compare the proviral DNA load and viral RNA load in plasma with clinical and immunological status for 29 patients infected by HIV-2 (subtype A in 17 and subtype B in 12). The proviral load (median, 201 copies/10(5) PBMC) was similar to that reported for HIV-1 infection. The median proviral loads did not correlate with the CD4(+) cell count categories and were as follows for CD4(+) cell counts of >400, 200 to 400, and <200 cells/mm(3), respectively: 121 copies/10(5) PBMC (n = 8; range, <5 to 712 copies/10(5) PBMC); 114 copies/10(5) PBMC (n = 9; range, <5 to 1,907 copies/10(5) PBMC); and 285 copies/10(5) PBMC (n = 12; range, 53 to 2,524 copies/10(5) PBMC). Proviral load did not correlate with plasma HIV-2 RNA positivity. As HIV-2 is considered to replicate less efficiently than HIV-1, these high proviral loads might be explained by the proliferation of infected cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724830      PMCID: PMC88534          DOI: 10.1128/JCM.39.12.4264-4268.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Low HIV-1 proviral DNA burden detected by negative polymerase chain reaction in seropositive individuals correlates with slower disease progression.

Authors:  M T Schechter; P W Neumann; M S Weaver; J S Montaner; S A Cassol; T N Le; K J Craib; M V O'Shaughnessy
Journal:  AIDS       Date:  1991-04       Impact factor: 4.177

2.  Improved detection of HIV-2 DNA in clinical samples using a nested primer-based polymerase chain reaction.

Authors:  O Grankvist; U Bredberg-Rådèn; A Gustafsson; J Albert; P Albino; P A Andreasson; A Nauclér; G Biberfeld; G Wadell
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

3.  Vertical transmission of HIV-2.

Authors:  S Matheron; C Courpotin; F Simon; H Di Maria; H Balloul; S Bartzack; D Dormont; F Brun Vezinet; A G Saimot; J P Coulaud
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 4.  Epidemiology of HIV-2 infection.

Authors:  K M De Cock; F Brun-Vézinet
Journal:  AIDS       Date:  1989       Impact factor: 4.177

5.  Molecular cloning of two west African human immunodeficiency virus type 2 isolates that replicate well in macrophages: a Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate.

Authors:  H Kühnel; H von Briesen; U Dietrich; M Adamski; D Mix; L Biesert; R Kreutz; A Immelmann; K Henco; C Meichsner
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

6.  Isolation of a simian immunodeficiency virus related to human immunodeficiency virus type 2 from a west African pet sooty mangabey.

Authors:  P A Marx; Y Li; N W Lerche; S Sutjipto; A Gettie; J A Yee; B H Brotman; A M Prince; A Hanson; R G Webster
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology.

Authors:  F Gao; L Yue; D L Robertson; S C Hill; H Hui; R J Biggar; A E Neequaye; T M Whelan; D D Ho; G M Shaw
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  HIV type 2 proviral load measured by quantitative polymerase chain reaction correlates with CD4+ lymphopenia in HIV type 2-infected individuals.

Authors:  N Berry; K Ariyoshi; O Jobe; P T Ngum; T Corrah; A Wilkins; H Whittle; R Tedder
Journal:  AIDS Res Hum Retroviruses       Date:  1994-08       Impact factor: 2.205

9.  Slower heterosexual spread of HIV-2 than HIV-1.

Authors:  P J Kanki; K U Travers; S MBoup; C C Hsieh; R G Marlink; A Gueye-NDiaye; T Siby; I Thior; M Hernandez-Avila; J L Sankalé
Journal:  Lancet       Date:  1994-04-16       Impact factor: 79.321

10.  Cellular and plasma viral load in patients infected with HIV-2.

Authors:  F Simon; S Matheron; C Tamalet; I Loussert-Ajaka; S Bartczak; J M Pépin; C Dhiver; E Gamba; C Elbim; J A Gastaut
Journal:  AIDS       Date:  1993-11       Impact factor: 4.177

View more
  20 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

2.  New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.

Authors:  Mélanie Bertine; Marie Gueudin; Adeline Mélard; Florence Damond; Diane Descamps; Sophie Matheron; Fidéline Collin; Christine Rouzioux; Jean-Christophe Plantier; Véronique Avettand-Fenoel
Journal:  J Clin Microbiol       Date:  2017-07-12       Impact factor: 5.948

3.  Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.

Authors:  Jérôme Legoff; Hicham Bouhlal; Gérard Grésenguet; Helen Weiss; Nzambi Khonde; Hakim Hocini; Nathalie Désiré; Ali Si-Mohamed; Jean de Dieu Longo; Cécile Chemin; Eric Frost; Jacques Pépin; Jean-Elie Malkin; Philippe Mayaud; Laurent Bélec
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

4.  Rapid discrimination between human immunodeficiency virus type 2 groups A and B by real-time PCR.

Authors:  Jean-Christophe Plantier; Marie Gueudin; Fabienne de Oliveira; Florence Damond; Véronique Lemée; Françoise Brun-Vézinet; François Simon
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 5.  Origins of HIV and the AIDS pandemic.

Authors:  Paul M Sharp; Beatrice H Hahn
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

6.  Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients.

Authors:  Geoffrey S Gottlieb; Stephen E Hawes; Nancy B Kiviat; Papa Salif Sow
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

7.  The Molecular Characterization of Intestinal Explant HIV Infection Using Polymerase Chain Reaction-Based Techniques.

Authors:  Laura Janocko; Andrew D Althouse; Rhonda M Brand; Ross D Cranston; Ian McGowan
Journal:  AIDS Res Hum Retroviruses       Date:  2015-08-24       Impact factor: 2.205

8.  Downregulation of the T-cell receptor by human immunodeficiency virus type 2 Nef does not protect against disease progression.

Authors:  Jérôme Feldmann; Aleksandra Leligdowicz; Assan Jaye; Tao Dong; Hilton Whittle; Sarah L Rowland-Jones
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

9.  Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections.

Authors:  Florence Damond; Marie Gueudin; Sophie Pueyo; Isabelle Farfara; David L Robertson; Diane Descamps; Geneviève Chène; Sophie Matheron; Pauline Campa; Françoise Brun-Vézinet; François Simon
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

10.  Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women.

Authors:  François Rouet; Didier K Ekouevi; André Inwoley; Marie-Laure Chaix; Marianne Burgard; Laurence Bequet; Ida Viho; Valériane Leroy; François Simon; François Dabis; Christine Rouzioux
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.